Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Eric T. Wong, M.D.

Co-Author

This page shows the publications co-authored by Eric Wong and Kenneth Swanson.
Connection Strength

6.521
  1. Wong ET, Swanson KD. Dexamethasone-Friend or Foe for Patients With Glioblastoma? JAMA Neurol. 2019 03 01; 76(3):247-248.
    View in: PubMed
    Score: 0.892
  2. Wong ET, Lok E, Swanson KD. Alternating Electric Fields Therapy for Malignant Gliomas: From Bench Observation to Clinical Reality. Prog Neurol Surg. 2018; 32:180-195.
    View in: PubMed
    Score: 0.853
  3. Wong ET, Swanson KD. Everolimus shortens survival of newly diagnosed glioblastoma patients. J Neurooncol. 2018 Oct; 140(1):179-180.
    View in: PubMed
    Score: 0.851
  4. Swanson KD, Lok E, Wong ET. An Overview of Alternating Electric Fields Therapy (NovoTTF Therapy) for the Treatment of Malignant Glioma. Curr Neurol Neurosci Rep. 2016 Jan; 16(1):8.
    View in: PubMed
    Score: 0.716
  5. Wong ET, Swanson KD. Response to: Comment on 'Dexamethasone exerts profound immunologic interference on treatment efficacy for recurrent glioblastoma'. Br J Cancer. 2015 Dec 01; 113(11):1633-4.
    View in: PubMed
    Score: 0.701
  6. Wong ET, Lok E, Swanson KD. An Evidence-Based Review of Alternating Electric Fields Therapy for Malignant Gliomas. Curr Treat Options Oncol. 2015 Aug; 16(8):40.
    View in: PubMed
    Score: 0.696
  7. Wong ET, Lok E, Swanson KD. Clinical benefit in recurrent glioblastoma from adjuvant NovoTTF-100A and TCCC after temozolomide and bevacizumab failure: a preliminary observation. Cancer Med. 2015 Mar; 4(3):383-91.
    View in: PubMed
    Score: 0.671
  8. Riley MM, San P, Lok E, Swanson KD, Wong ET. The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma. J Vis Exp. 2019 04 16; (146).
    View in: PubMed
    Score: 0.225
  9. Timmons JJ, Zhang K, Fong J, Lok E, Swanson KD, Gautam S, Wong ET. Literature Review of Spinal Cord Glioblastoma. Am J Clin Oncol. 2018 12; 41(12):1281-1287.
    View in: PubMed
    Score: 0.219
  10. Lok E, Swanson KD, Wong ET. Tumor treating fields therapy device for glioblastoma: physics and clinical practice considerations. Expert Rev Med Devices. 2015; 12(6):717-26.
    View in: PubMed
    Score: 0.177
  11. Gera N, Yang A, Holtzman TS, Lee SX, Wong ET, Swanson KD. Tumor treating fields perturb the localization of septins and cause aberrant mitotic exit. PLoS One. 2015; 10(5):e0125269.
    View in: PubMed
    Score: 0.172
  12. Lok E, Chung AS, Swanson KD, Wong ET. Melanoma brain metastasis globally reconfigures chemokine and cytokine profiles in patient cerebrospinal fluid. Melanoma Res. 2014 Apr; 24(2):120-30.
    View in: PubMed
    Score: 0.159
  13. Wong ET, Lok E, Swanson KD, Gautam S, Engelhard HH, Lieberman F, Taillibert S, Ram Z, Villano JL. Response assessment of NovoTTF-100A versus best physician's choice chemotherapy in recurrent glioblastoma. Cancer Med. 2014 Jun; 3(3):592-602.
    View in: PubMed
    Score: 0.157
  14. Locasale JW, Melman T, Song S, Yang X, Swanson KD, Cantley LC, Wong ET, Asara JM. Metabolomics of human cerebrospinal fluid identifies signatures of malignant glioma. Mol Cell Proteomics. 2012 Jun; 11(6):M111.014688.
    View in: PubMed
    Score: 0.034
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.